Flex Work policy
Corporate Policy
Full time in office
About
Ouro Medicines is a biotechnology company focused on developing novel treatments for debilitating and life-threatening diseases using its proprietary therapeutic platform based on species-specific therapeutics. Established in August 2019 as a spin-out from leading synthetic biology company Ginkgo Bioworks and headquartered in Boston, Massachusetts, the company’s aim is to bring the benefits of synthetic biology to patient populations that require new therapeutic options. The company's vision is to pave the way to a new generation of cures by unlocking the therapeutic capabilities of the human genome.
This content was generated by A.I. Ouro Medicines employees can
to make any changes.